The Los Angeles Post
U.S. World Business Lifestyle
Today: March 21, 2025
Today: March 21, 2025
Ludwig Burger

Ludwig Burger

Staff Writer

Latest From Ludwig Burger

Business|Europe|Finance|Health|Stock Markets

Roche secures Zealand obesity drug candidate for up to $5.3 billion

Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, as the Swiss drugmaker

Roche secures Zealand obesity drug candidate for up to $5.3 billion
Business|Europe|Finance|Stock Markets

Bayer share drop draws market regulator's scrutiny, source says

Germany's financial markets watchdog has started an initial probe to examine whether Bayer fairly disclosed plans to get shareholder approval for a potential

Bayer share drop draws market regulator's scrutiny, source says
Business|Europe|Finance|Stock Markets

Bayer told analysts of cash call plan a day before official statement

Bayer told several brokerages about plans to seek shareholder permission to issue shares one day before formally announcing the news on Friday, which weighed

Bayer told analysts of cash call plan a day before official statement
Business|Economy|Environment|Europe|Health|Political|US

Bayer tells US it could halt Roundup weedkiller sales over legal risks

Bayer has told U.S. lawmakers it could stop selling Roundup weedkiller unless they can strengthen legal protection against product liability

Bayer tells US it could halt Roundup weedkiller sales over legal risks
Business|Economy|Europe|Finance

Bayer sees improvement in 2026 after profit decline this year

Bayer on Wednesday raised the prospect of a return to earnings growth from 2026 after a decline this year, lifting its shares to a four-month high as its CEO

Bayer sees improvement in 2026 after profit decline this year
Business|Economy|Health|Science

Next generation weight loss drugs aim to save muscle

About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, clinical trial experts and doctors

Next generation weight loss drugs aim to save muscle
Business|Economy|Europe|Health

Novartis buys Blackstone's Anthos for up to $3.1 billion

Swiss pharmaceutical giant Novartis has agreed to acquire Anthos Therapeutics, a biopharma firm majority-owned by Blackstone's drug development unit, for

Novartis buys Blackstone's Anthos for up to $3.1 billion
Business|Europe|Finance|Health

Roche sees high single-digit core profit growth in 2025

Roche said on Thursday it is targeting a continued increase in adjusted earnings per share (EPS) at a high single-digit percentage this year, helped by lower

Roche sees high single-digit core profit growth in 2025
Business|Europe|Finance|Technology

SAP sees higher 2025 operating profit, as AI services catch on

SAP, Europe's largest software maker, said on Tuesday it was more optimistic about its financial results this year due to faster growth in

SAP sees higher 2025 operating profit, as AI services catch on
Crime|Election|Europe|Political

German government, opposition clash over rival border policies

Germany's government and opposition parties duelled on Monday over rival border control policies, with opposition leader Friedrich Merz, favourite

German government, opposition clash over rival border policies
Election|Europe|Political

Chancellor hopeful says Germany should focus on existing NATO spending target

The leader of Germany's conservative CDU, the party's candidate to run for chancellor, said on Tuesday that the nation should focus on efforts to reach existing

Chancellor hopeful says Germany should focus on existing NATO spending target
Science

Nobel Chemistry prize awarded for 'quantum dots' that bring coloured light to screens

Scientists Moungi Bawendi, Louis Brus and Aleksey Ekimov won the 2023 Nobel Prize in Chemistry for their discovery of tiny clusters of atoms

Nobel Chemistry prize awarded for 'quantum dots' that bring coloured light to screens
Business|Finance|Health|Stock Markets|US

Pfizer, BioNTech shares fall on COVID product sales uncertainty

Shares of Pfizer and German partner BioNTech fell on Monday after the U.S. drugmaker slashed the sales forecast for its COVID vaccine and therapy last week, and some

Pfizer, BioNTech shares fall on COVID product sales uncertainty
Business|Economy|Europe|Finance|Health|Technology|US

Lilly to build $2.5 billion diabetes drug plant in Germany

Eli Lilly will build its first plant in Germany for 2.3 billion euros ($2.5 billion) in the western town of Alzey, the U.S. pharmaceuticals maker said on

Lilly to build $2.5 billion diabetes drug plant in Germany
Business|Europe|Health

Bayer woes pile up as blood thinner drug trial fails

Germany's Bayer has aborted a large late-stage trial testing a new anti-clotting drug due to lack of efficacy, dealing a fresh blow to the embattled drugmaker and throwing

Bayer woes pile up as blood thinner drug trial fails
Business|Finance|Health

Roche joins race for obesity drugs with $2.7 billion Carmot deal

Roche agreed to take over obesity drug developer Carmot Therapeutics for $2.7 billion, joining a list global contestants seeking to challenge the dominant makers of weight

Roche joins race for obesity drugs with $2.7 billion Carmot deal
Business|Finance|News|Stock Markets|US

Bayer's first-quarter adjusted profit falls less than expected

Bayer beat first-quarter analyst forecasts as it reported a slight drop in adjusted earnings on Tuesday, providing a respite for the CEO's turnaround efforts.

Bayer's first-quarter adjusted profit falls less than expected
Business|Europe|Finance

Thyssenkrupp board approves partial sale of steel unit to billionaire Kretinsky

Thyssenkrupp on Thursday said its supervisory board approved a planned sale of 20% of the conglomerate's steel division to Czech billionaire

Thyssenkrupp board approves partial sale of steel unit to billionaire Kretinsky
Business|Health|Science

Eli Lilly: still seeking UK approval on pen for weight-loss drug

Eli Lilly on Thursday said it has not yet gained approval in Britain for the injection pen it plans to use for its Mounjaro drug against obesity and

Eli Lilly: still seeking UK approval on pen for weight-loss drug
Business|Health|News|Science

Roche to halt trial in latest setback for lung cancer immunotherapy

Roche will end a lung cancer trial testing its new immunotherapy after the drug did not show a benefit over established treatment Keytruda by Merck

Roche to halt trial in latest setback for lung cancer immunotherapy
Crime|Europe|Health

Sellers of fake Ozempic to face charges in Austrian court

Austrian prosecutors said they will bring criminal charges against two men accused of selling fake versions of Novo Nordisk's diabetes drug

Sellers of fake Ozempic to face charges in Austrian court
Europe|News|World

German army wants to order 100 Boxer vehicles from KNDS, Spiegel says

Germany's armed forces are in talks to order about 100 Boxer armoured vehicles from German-French defence contractor KNDS for use by Ukraine, news

German army wants to order 100 Boxer vehicles from KNDS, Spiegel says
Business|Europe|Finance|Stock Markets

Germany's Lufthansa cuts 2024 profit target for a second time

Deutsche Lufthansa slashed its 2024 earnings guidance for a second time and issued a profit warning for its second

Germany's Lufthansa cuts 2024 profit target for a second time
Business|Health|Science

Bayer eyes wider Nubeqa use on new prostate cancer trial data

Bayer said on Wednesday its Nubeqa drug was shown to slow the progression of a certain type of prostate cancer in a late-stage trial, underpinning growth

Bayer eyes wider Nubeqa use on new prostate cancer trial data
Business|Health|Technology

Roche touts early trial success of second obesity drug candidate

Roche said on Wednesday a second drug candidate from its purchase of Carmot Therapeutics yielded positive results in an early-stage trial, as the Swiss

Roche touts early trial success of second obesity drug candidate

Follow